ClinicalTrials.Veeva

Menu

Iron Therapy in Erythropoietic Protoporphyria

B

Bispebjerg Hospital

Status

Completed

Conditions

Iron-deficiency
Erythropoietic Protoporphyria

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

Giving oral iron to patients with erythropoietic protoporphyria (EPP) who is iron deficient is thought to be beneficial. This is, however, not well documented. The purpose of this study is to investigate the effect and safety of oral iron in patients with EPP who is taking iron tablets due to iron deficiency.

Enrollment

10 patients

Sex

All

Ages

15+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Diagnosed with EPP
  • Taking standard dose of iron tablets due to iron deficiency

Exclusion criteria

  • Pregnant
  • Lactating

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems